30 Govt.
Since Dec 10, 2005

view home page, enter name:
Three-drug combination prolongs survival in men with metastatic, hormone-sensitive prostate cancer (32.5% lower death rate at 3.5 years)
https://freerepublic.com/focus/f-chat/4039736/posts